The global carrier screening market is anticipated to touch USD 4,200 million at a 16.8% CAGR between 2019- 2025, according to the new report by Market Research Future (MRFR). Carrier screening, simply put, is a genetic test that is used for determining whether a healthy individual is a carrier of any recessive genetic disease. It has wide applications in clinics, physician offices, reference laboratories, hospitals, and others.
Various factors are adding to the global carrier screening market growth. As per the latest MRFR report, these factors comprise growing awareness about carrier screening, technological advances, growing emphasis on early detection & prevention, increasing number of players involved new carrier screening technology development, and new product launch.
On the contrary, lack of standard guidelines, accuracy issues, the impact of COVID-19, and scarcity of skilled professionals are factors that may limit the global carrier screening products market growth over the forecast period.
Market Segmentation
The MRFR report gives an inclusive segmental analysis of the global carrier screening market report based on end users, technology, medical condition, type, and product & service.
By product and service, the global carrier screening market growth is segmented into products & services. Of these, the product segment will lead the market over the forecast period, followed by the services segment that is likely to grow at a fast pace.
By type, the global carrier screening market is segmented into targeted disease carrier screening and expanded carrier screening. Of these, the expanded carrier screening will dominate the market over the forecast period, followed by the targeted disease carrier screening segment that is likely to grow at a quick pace.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/8755
By medical conditions, the global carrier screening market is segmented into neurological conditions, haematological conditions, pulmonary conditions, and others.
By technology, the global carrier screening market growth is segmented into microarrays, polymerase chain reaction, and others.
By end user, the global carrier screening market is segmented into clinics, physician offices, reference laboratories, hospitals, and others.
Regional Analysis
Based on the region, the global carrier screening market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), & the Middle East and Africa. Of these, the Americas will have the lions share in the market over the forecast period. Increasing awareness about genetic disorders & its diagnosis methods, and the huge patient population suffering from genetic diseases are adding to the global carrier screening market growth in the region.
The global carrier screening market in Europe is predicted to hold the second-largest share over the forecast period. The presence of several healthcare companies, rising focus on personalized medicine, and increasing R&D activities are adding to the global carrier screening market growth in the region.
The global carrier screening market in the APAC region is predicted to grow at a fast pace over the forecast period. Increasing awareness regarding the diagnosis techniques of genetic disorder coupled with increasing market growth is adding to the global carrier screening market growth in the region.
The global carrier screening market in the MEA is predicted to have the smallest share over the forecast period for a low per capita disposable income, especially in Africa’s underdeveloped regions, lack of awareness regarding the disease condition, and limited healthcare infrastructure.
Key Players
Leading players profiled in the global carrier screening market report include Laboratory Corporation of America Holdings (US), Natera Inc (US), Luminex Corporation (US), Thermo Fisher Scientific Inc (US), Illumina Inc (US), Myriad Genetics (US), Sema4 (US), Quest Diagnostics Incorporated (US), Fulgent Genetics Inc (US), Opko Health (US), Invitae Corporation (US), and Eurofins Scientific (Luxembourg). Industry players have incorporated different strategies to create a niche in the market, such as acquisitions, mergers, new product launches, and more.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/sample_request/8755
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
Global Carrier Screening Market Research Report, by Product & Service (Services and Products), Type, Medical Condition Technology, End-User and Region - Forecast till 2027Market SynopsisGlobal Carrier Screening Market 2020 is poised to hold a value of about USD 4.20 billlion by 2025 and is slated to mature at a CAGR of 16.8% from 2019 to 2025.Market HighlightsThe key driving factor in the growth of the carrier screening market is the growing research and development operation and the introduction of carrier screening products for genetic disease testing.
Demand development for carrier screening items is boosted by the increased launch of items.
The increase in recognition and the number of persons with genetic abnormalities results in the need for screening testing for carriers.In order to diagnose foetal defects, businesses working in the global carrier screening industry mainly follow the next generation sequencing (NGS) strategy.
Manufacturers are making continuous efforts to upgrade the current technology and implement a new revolutionary technology in the market.
Latest developments in genetic science have catapulted carrier screening solutions from gene-by-gene testing to panels covering several diseases at one time.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8755 SegmentationBased on product & service, form, medical condition, technology, and end users, the Global Carrier Screening Market has been segmented.The goods & service-based business has been separated into goods and services.
It is projected that the extended carrier screening category will have the highest market share throughout the forecast period.The industry is segmented into respiratory disorders, haematological disorders, neurological conditions, and others dependent on medical conditions.The market has been segmented into polymerase chain reaction, microarrays, and others by technology.The industry is segmented into hospitals, reference labs, medical offices, and clinics, among others dependent on end-users.Regional OverviewThe Americas holds the largest market share in the global carrier screening market.
Market HighlightsAccording to MRFR analysis, the Global Carrier Screening Market is expected to register a CAGR of 16.8% during the forecast period of 2019 to 2025 and is anticipated to reach USD 4,200 Million by 2025.The growth of the global carrier screening market is driven by various factors, such as the increasing launch of carrier screening products and growing numbers of players involved in the development of new carrier screening technologies.
In addition, the rising awareness program about genetic disorders supports the market growth during the forecasted period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/8755However, the lack of skilled professionals and accuracy issues of carrier screening products may hamper market growth.Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The high occurrence of inherited diseases such as sickle cell anemia, X linked disorders and among other disorders in the US is one of the reasons for the growth of the market in the country.
The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The carrier screening market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The carrier screening market in the Middle East & Africa has been divided into the Middle East and Africa.SegmentationThe Global Carrier Screening Market has been segmented based on Product & Service, Type, Medical Condition, Technology, and End Users.The market, based on product & service, has been divided into products and services.
